chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Continued Vertigo since second shot.  Not requiring medical attention but bothersome  and effects daily tasks
Enlarged Heart,  Scheduled Echocardiogram for 09/23/2021, and 48 hour monitoring of heart.
Received shot due to accidental razor cut while cleaning windows. Injection spot turned red, hot and hard. It swelled a lot and increased in size over 3 days. I ache and feel like I have the flu.
There was no adverse event related to this vaccination. I developed COVID-19 on May 31, 2022.
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's concomitant medications included sterile diluent (MERCK STERILE DILUENT) lot# M039200 expiration date 03-MAY-2019. The patient's medical history, concurrent conditions and drug reactions/allergies were not provided. On 09-FEB-2018, the patient was vaccinated with an improperly stored dose of PROQUAD injection, lot # N022972, expiration date 19-FEB-2019, for prophylaxis (frequency, route and anatomical location were not provided). The administered dose of vaccine experienced a temperature excursion in the range between 6°F to 14°F during 6 hours as recorded by a data logger. The vaccines had not had any previous temperature excursions. There was no adverse effect reported. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1803USA003986: US-009507513-1803USA007256: US-009507513-1803USA007257: US-009507513-1803USA007258: US-009507513-1803USA007259:
Vaccine order was placed incorrectly, and I went to give the vaccine found the "accurate" lot number and administered the vaccine, although it was for 65 und
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. Reporter that an unspecified number of unspecified patients received improperly stored doses of RECOMBIVAX HB (lot# was not reported) on unspecified dates. No adverse effect reported. Additional information has been requested.
She could not get the second dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jul-2021 and was forwarded to Moderna on 21-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (She could not get the second dose) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Amlodipine 10mg, CELECOXIB (CELEXA [CELECOXIB]) and LEVONORGESTREL (MIRENA L) for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She could not get the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (She could not get the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.
Information has been received on 10/23/01 from a health professional concerning a 53 year old female who on 10/11/01 was vaccinated with "the standard dose", 0.5ml, of pneumococcal vaccine 23 polyvalent (lot 637487/1071K) and 1 dose of influenza virus vaccine. On 10/15/01, the pt went to the MD's office with a local reaction that was described as an area at the injection site that was swollen, red and hot. The pt also had symptoms of a sinus infection, with a cough and a fever. She was dx'd with cellulitis and was prescribed Augmentin for the sinus infection and the cellulitis, Atuss and Medrol. It was noted that the pt "is fine now" and has fully recovered. The reporter noted that the practice had been administering the pneumococcal vaccine 23 polyvalent vaccine for years and they have never had a problem. It was also noted that another pt (WAES 01106301) who was vaccinated from the same lot developed similar events. The reporter stated that she and another nurse are now concerned and afraid to use the rest of the lot. The reporter stated that she was grateful that a check would be done on this lot and reported that their practice would not administer any more of the vaccine until they received information on the results of the lot check. The records of testing prior to release of this lot have been checked by compliance and found to be satisfactory. This lot complies with the standards of the CDC and was released. Upon internal review, the pt's cellulitis was considered to be an "Other Important Medical Event". Additional information has been requested. F/U states the pt was also prescribed Augmentin for the sinus infection.
Received first Shingrix vaccine and got shingles for the first time a few days later. (Scalp, neck, and tonsi all on left side). Battling PHN ever since.  All joints and muscles ache & difficulty walking. I used to walk one hour a day & can hardly walk anymore. This vaccine changed my life. Never got the second shot. Very disappointed.
UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included UTI (recently hospitalized for it on 12JAN2021.).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Information was received regarding a 4 year old male who received Acel-Imune, Orimune, and MMR II vaccines on 04/08/98. The child's mother reported that he developed a fever post-vaccination. She also reported that he experienced seizures in his face and body, followed by lethargy. According to his mother the child was diagnosed with temporal lobe damage, and he was unable to walk or talk. She considered the events to be life-threatening and disabling. Merck Sharp & Dohme considered seizures to be medically important. On follow-up, the child's physician indicated that the mother reported that the child experienced headache, mood changes, and behavior changes on 04/11/98. On approximately 04/16/98, the child developed head, mouth, and arm twitching, primarily on his right side. He was losing balance "fully", he had stopped talking, and began staring and drooling. The symptoms reportedly worsened and continued for 1.5 months. The mother reported that the child "acted like a vegetable after 2 months." The child was hospitalized and was noted to be "very combative". The result of an MRI performed in June 1998 was negative, and a "spec scan" showed temporal lobe "involvement". As of 04/30/01, the child was being treated with "Respiritotal" and Depakene (valproic acid).
pt recvd vax 1005AM & @ approx 1130AM started exp severe h/a, blurring vision, tunneling of vision; mom brought pt back to office; mom gave APAP @ 1155AM; BP & pulse nl;
Pt started with edema and erythema directly over MMR vaccine site 24 hours after injection. Slowly got worse, no pain, then receded within next 24 hours.
10/14/16 - received flu vaccine. 10/15/16 - otherwise doing well but while playing at a restaurant, had a seizure (self resolving within 1 min).
Pain in arm,  under arm pain, neck lower back,  chest pain,  fatigue,  Dizzy off and on.
My  upper lip started to tingle and feel itchy, and upon checking it was very swollen on the underside. My gums felt like they were throbbing and my mouth and tongue felt uncomfortable and itchy for about 2 hours.
1. Erythema around injection site, non tender induration of muscle about 7cm - L thigh.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-SEP-2014, the patient was vaccinated with a dose of GARDASIL (route of administration, lot number, expiration date, dose and frequency were not reported). On 28-SEP-2016, the patient was vaccinated with a dose of GARDASIL 9 (route of administration, lot number, expiration date, dose and frequency were not reported). The physician made the decision that this would be the dose 2 of the HPV series. Subsequently, on 18-OCT-2016, the patient inadvertently received a dose of GARDASIL 9 (route of administration, lot number, expiration date, dose and frequency were not reported). No symptoms were reported. Additional information has been requested.
24hrs p/vax arm blew up to size of a baseball w/redness & was hot;p/3 days went to the ER & had x-rays (to check for abscess);
Information has been received from a licensed practical nurse concerning a 15 year old male described as a health male with no reported medical history (allergies unknown) who on 10-JUL-2006 was vaccinated with a dose of Varivax (lot # 652868/0267F). On 24-JUL-2006 the patient developed a generalized rash over trunk and face. He also had itching of the rash. Medical attention was sought. On 29-JUL-2006, the patient recovered. It was reported that the office was deciding whether to give the patient a second dose. There was no product quality complaint involved. Additional information has been requested.
26APR94 2PM started having hives on back-spread in 2hr to underarms, & inject site; fever 100;
This spontaneous report as received from a pharmacist refers to a 41 years old female patient with no drug allergies or reactions and no pertinent medical history. On an unknown date the patient was vaccinated with a dose of MMR II. No other co-suspects were reported. No concomitant medications were reported. It was reported that the patient who immigrated six years ago reported of being vaccinated against measles vaccine in childhood and again six years ago as a part of immigration requirements. On an unknown date in 2012 the patient experienced negative or equivocal measles titers. No treatment was given. The patient sought medical attention, he contacted the pharmacist. The outcome of negative or equivocal measles titers was reported as not recovered. The pharmacist reported that the patient had no details about the brand name of vaccines she received or specific doses or dates. Additional information has been requested.
Heart attack; A spontaneous report was received from a consumer, who was also a female patient of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a heart attack (myocardial infarction).  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an undisclosed date, the patient received their first of two planned doses of mRNA-1273 (lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an undisclosed date after receiving mRNA-1273, the patient had a heart attack. The patient stated that Moderna should have told her "about the montelukast allergy".  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, heart attack, was unknown.; Reporter's Comments: Very limited information regarding this event of heart attack has been provided at this time. Patient's age, medical history, list of concomitant medications, onset date and clinical details of the event is lacking. Further information has been requested.
pt reports inc in severity of arthritis sx (joint pain) 1 days p/vax; seen by MD 15JUN92; tx w/pain med; MD advised pt to delay 2nd dose of vax until arthritis pain has subsided;
Patient received her first Pfizer Covid-19 vaccine on 7/29/2021 and on 7/30/2021 patient notices cellulites on her left arm were she received the vaccine. .Patient was seen by health professional and was started on Keflex , ibuprofen, and an antihistamine.
7AUG98 lt arm Td h/a 24hr later very sore, swollen, fever-1wk later to MD scraped w/nail (fingernail) pus poured out MD put pt on ATB for 7 days;arm is ok now;
Pt was given the Covid 19 Pfizer-BioNTech in stead of the Covid 19 Pfizer-BioNTech Bivalent.  Spoke with pt and at this time she has no adverse reaction.
Upon injecting vaccine pt. slightly pale and stated she felt lightheaded.  EMS called to chair. BP 120/70, HR 100, SO2 99%.  10:30AM  Pt has a second episode of light headed.  BP 160/90, SO298%.HR 91.PT states she had similar episode after her first injection and when she would give blood.  No significant medical history.  A second period of feeling lightheaded so pt laid  down and about 5 min started improving. Pt was discharged from facility at 11:30AM and pt stated feeling a lot better.  Pt had husband transported her back home.  Pt needed no additional assistance and was felling asymptomatic at the time of discharge.  Pt was monitored for a total of 1 hour 27 min.
13 y/o female received 1st vaccine dose on 5/22/2021 which was Moderna (Lot #047A21A,  Exp-09/01/21). *No parent/guardian signature on consent form. Staff portion  was not completed. Received Moderna at age 13.  Now 14 y/o female received 2nd dose on 6/26/2021 which was also Moderna (Lot #047A21A, Exp-09/01/21). *Consent signed by minor, not by parent/guardian.  No medical adverse reactions noted or reported at this time.
On 02/06/2021 at 12:10 pm at church . I start having  severe nose bleeding for  almost 1hr. Went  to ER. By ambulance .. My blood pressure was 178/93. Then started having  severe  nose bleeding 02/07/2021at 11pm . Bleeding was very severe it less about 45 min . When I pressure my nose blood pour out both eyes and mouth . Bp was 168/90  I take very small dose of bp meds . Atacand 8 mg for last 13 years . It has been control last 13 years. I weight 107 pound . I walk 4 mile 1 1/2 hrs a day and yoga at night for 1 hr. Eat very healthy diet . All this severe nose bleeding started  3 days after Covid Vaccine received . I am lucky  this bleeding didn?t happen in my brain .it?s very scarily.
Case number PHEH2015US20340, is an initial spontaneous report received from a pharmacist on 08 Oct 2015. This report refers to a 33 year old female patient. Historical condition and concomitant medication were not provided. The patient was vaccinated with FLUVIRIN (batch number: 157602) intramuscularly on 06 Oct 2015. On the same day after vaccination, the patient experienced itching all over without any rash. The patient also had intermittent sharp pain. Outcome of the events were unknown. Seriousness and causality of the events were not reported.
Arm pain at injection site of left arm.   Swollen lymph nodes and pain under the left armpit.
gave Flublok to pregnant woman/No AE; Initial information was received on 10-Dec-2019 regarding an unsolicited valid non-serious case from non-healthcare professional (office staff).  This case involves female patient of an unknown age who received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], while she was pregnant.   Data regarding this pregnancy were received prospectively.  The date of last menstrual period was not reported.  The estimated due date was not reported.  Medical history, medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route, at an unknown administration site.  It was case of vaccine exposure during pregnancy. The patient was pregnant when she received vaccine.  It was unknown whether patient experienced any adverse reaction after the injection.  Pregnancy outcome was unknown at the time of report.  Information on the batch number was requested.
Per patient report was seen for what she describes as a heat rash across her lower back on the day 2 weeks following her Shingrix injection. MD said it was shingles per patient and treated as such. Encourged patient to have administering pharmacy report to VAERS
No adverse event; 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023).    Concomitant medication was not reported. The vial was initially thawed on 27-Jun-2023.  Treatment medication was not reported.  This case is for 28th patient out of 30 patients reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732645 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live Follow-up received contains Vaccine administration date.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732645:Master case (Patient 1)
No adverse rashes, however received VARIVAX X 1, now with active varicella after touching boyfriend's active zoster lesions. Mom also reported she had what mom thought was varicella in 6/97 (not seen in office).
After being administered the vaccine, patient noticed a 9x4 inch erythema directly under the armpit. The erythema was warm to touch, swollen and tender. Patient went to the doctors office and saw a nurse practitioner on Wednesday (2/1/17) who stated that patient has a history of using Humira.
I had a local reaction (red, raised, circular burning itching) to the Moderna vaccine with each injection (total of 4). A few days after the last injection I had a severe allergic reaction including numbness in my lips, ears, face and neck. Also, flushing, severe burning sensation (worse than menopause!,) raised/red/itching hives on my back and face and chest and anxiety. It lasted for approximately 30 minutes and completely resolved until the next day at approximately the same time. This happened daily and my PCP could not diagnose or treat it. I went to the allergy clinic where they did labs (all negative) and started me on Singular which seemed to help marginally. I tried oral and im steroids with marginal relief. The severe reaction continued daily, regardless of interventions, until approximately 2 months ago, when the intensity began to lessen and shortly after the frequency lessened. They continue to this day with mild symptoms 2-4 times per week. I just learned about this site today.
Admitted to the hospital for 3 days for possible stroke. Had Tremmers, bad headache, two(2) knots in left arm painful, chest pain, right breast pain, high fevers, diabetes numbers very high These went on for 2 1/2 days was flushed with saline and aspirin and Tylenol.
Information has been received from a healthcare professional concerning her 31 month old Caucasian / Hispanic daughter with an amoxicillin allergy (hives - February 1999) who on 07/29/98 was vaccinated with a 1st dose of Varicella virus vaccine live SC in the left arm. There was no post-vaccination rash. On 02/24/00, the patient was inadvertantly vaccinated with a 2nd dose of Varicella virus vaccine live that had expired on 02/20/00. On the morning of 02/29/00 the patient had 50+ pox with a fever of 101 F and a runny nose. In the evening that same day the child had 100+ pox and a temperature of 100 F. On the morning of 03/02/00, the child had 300+ pox and no temperature. By later that evening her pox had decreased to less than 150. By 03/04/00 all of the child's pox had crusted over. It was noted that the patient breast-fed until mid May 1998, during which time her mother had varicella. The reporter felt that the patient's experience was an Important Medical Event. No further information is available.
Patient presented with all over body rash on Sunday evening, ER doctor let patient know to never take the second dose.
Pt called 5/5/2016 to report that she noted redness and swelling at the site of the vaccination - swelling tracked down her arm as did the erythema. She took a picture of it and it was quite impressive. It took until 5/10/16 for it to nearly resolve. She treated with ice and at our advice, ibuprofen. This was helpful.
spleen removed 09Jan2022 from blood clots; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 21-year-old male patient received bnt162b2 (BNT162B2), on 15Jun2021 as dose 2, single (Batch/Lot number: unknown) at the age of 20 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: 25May2021, when the patient was 20-year-old, for Covid-19 Immunization. The following information was reported: THROMBOSIS (hospitalization, disability, medically significant, life threatening) with onset 09Jan2022, outcome "recovering", described as "spleen removed 09Jan2022 from blood clots". The event "spleen removed 09jan2022 from blood clots" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of thrombosis including Splenectomy.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the temporal relationship, the association between the event thrombosis with BNT162b2 can not be fully excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Between Aug90 + Nov90 pt vax w/ 3rd hepta B from was expired lot. no adverse reaction.
No sx 28MAY91; Awake 29MAY91 @ 0645 w/swollen face, eyes almost swollen shut, little red dots on arms, legs, neck & face; Seen by MD who thought a probable shot rxn; Given Pred & DPH; Given shot for itching;
A day or 2 after injection, redness and swelling in site, very itchy, pt. determined allergy to vaccine.
Pt recvd 2 doses of Engerix-B & p/2nd dose had weakness in lt arm (site of inject); 19JUN92 later in the evening devel a fine tremor when holding objects in lt hand; 22JUN92 seen by MD;
At time of injection pt stated it burned more than usual. She took some Ibuprofen that night b/c I told her, her arm may be sore. She said there's a big bruise over the injection site & from her shoulder to her elbow is all red (appeared the day after injection).